Taconic Is Acquired by Avista


Taconic, a portfolio company of H.I.G., sale to Avista


Taconic Biosciences, Inc. (“Taconic” or the “Company”), a portfolio company of H.I.G. Capital (“H.I.G.”), has been acquired by Avista Capital Partners (“Avista”). Terms of the transaction were not disclosed.

Baird served as lead financial advisor to Taconic on this transaction.


Taconic Biosciences, Inc. is one of the world’s leading suppliers of murine research models for pharmaceutical, biotechnology, CRO, and academic research clients. Specializing in genetically engineered models, precision research models, and integrated model design and husbandry services, Taconic supports research in oncology, immunology, neurology, and a variety of other established and emerging therapeutic areas. Headquartered in Rensselaer, New York, with operations in Indiana, Germany, and Denmark, Taconic also maintains distributor relationships in Asia and has global shipping capabilities to provide models almost anywhere in the world.

H.I.G. is a leading global alternative assets investment firm with over $52 billion of equity capital under management. Based in Miami, Florida and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the U.S., as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro and São Paulo, H.I.G. specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused/ value-added approach. Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. H.I.G.’s current portfolio includes more than 100 companies with combined sales in excess of $30 billion.

Founded in 2005, Avista Capital Partners is a leading New York-based private equity firm with over $8 billion invested in more than 40 growth-oriented healthcare businesses globally. Avista partners with businesses that feature strong management teams, stable cash flows and robust growth prospects – investing in the medical devices, pharmaceuticals, outsourced pharmaceutical services, healthcare technology, healthcare distribution and diagnostics, and consumer healthcare sectors. Avista’s Strategic Executives and Advisors are an integral part of the team, providing strategic insight, operational oversight and senior counsel, which helps drive growth and performance, while fostering sustainable businesses and creating long-term value for all stakeholders.

Taconic, a portfolio company of H.I.G., sale to Avista

November 2022
Taconic Biosciences, Inc.
M&A - Sellside
Pharmaceutical Services
Target Geography
North America
Acquiror Geography
North America